Skip to main content
profile image
Selected Works of John M. Pagel, MD, PhD
Article
G‐CSF Priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm
American Journal of Hematology (2015)
  • Pamela S. Becker, Fred Hutchinson Cancer Research Center
  • Bruno C. Medeiros, Stanford University
  • Anthony S. Stein, City of Hope National Medical Center
  • Megan Othus, Fred Hutchinson Cancer Research Center
  • Frederick R. Appelbaum, Fred Hutchinson Cancer Research Center
  • Stephen J. Forman, City of Hope National Medical Center
  • Bart L. Scott, Fred Hutchinson Cancer Research Center
  • Paul C. Hendrie, University of Washington
  • Kelda M. Gardner, University of Washington
  • John M. Pagel, Fred Hutchinson Cancer Research Center
  • Roland B. Walter, Fred Hutchinson Cancer Research Center
  • Cynthia Parks, University of Washington
  • Brent L. Wood, University of Washington
  • Janis L. Abkowitz, University of Washington
  • Elihu H. Estey, Fred Hutchinson Cancer Research Center
Link
Disciplines
Publication Date
April 1, 2015
DOI
10.1002/ajh.23927
Citation Information
Pamela S. Becker, Bruno C. Medeiros, Anthony S. Stein, Megan Othus, et al.. "G‐CSF Priming, clofarabine, and high dose cytarabine (GCLAC) for upfront treatment of acute myeloid leukemia, advanced myelodysplastic syndrome or advanced myeloproliferative neoplasm" American Journal of Hematology Vol. 90 Iss. 4 (2015) p. 295 - 300
Available at: http://works.bepress.com/john-pagel/67/